Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS vs Flexible GnRH Antagonist in Poor Ovarian Responders
NCT07736261Phase 2Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of drospirenone in infertility, Diminished Ovarian Reserve (DOR). Planned start Aug 2026; status: not yet recruiting.
02
Drugs
drospirenone
03
Conditions
infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07736261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07736261.